SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Amgen Inc. (AMGN) -- Ignore unavailable to you. Want to Upgrade?

To: rainwater who wrote (507)3/12/1998 4:01:00 AM
From: Celso  Respond to of 1906
 
I seriously doubt it. I would say Amgen would have to be in the low 40's to even become a candidate. Amgen management does not want to be a candidate for takeover. I believe they are doing what they can to keep the EPS up. With any luck from HCFA, the reimbursement policy might be turned around and we might just see the 70's by September.



To: rainwater who wrote (507)3/12/1998 9:15:00 AM
From: Xpiderman  Read Replies (1) | Respond to of 1906
 
Per BriefingCom:

Amgen (AMGN) 55: CNBC reports that new Medicare procedures are expected to increase Epogen sales, and Salomon Smith Barney says stock could go up $10 in the next few days...

AMGN is bidding up to $59 1/8 (+4 1/8) before market opens.


HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2025 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News